Molecular-neurobehavioral associations in females with the fragile X full mutation

M. T. Abrams, A. L. Reiss, L. S. Freund, T. L. Baumgardner, G. A. Chase, Martha Bridge Denckla

Research output: Contribution to journalArticle

Abstract

In this study, young females with the fragile X [fra(X)] full mutation (fM) were assessed using quantitative measures of mutation amplification size (Amp) as well as the ratio of active normal X chromosome to total normal X chromosome (activation ratio-AR). Neurobehavioral assessments of females with the fM were performed and included specific and general measures of cognitive and behavioral/developmental functioning. To investigate molecular- behavioral associations, Amp and AR were used as independent variables, while cognitive and behavioral scores were used as dependent variables. Significant correlations were observed between both molecular variables (Amp and AR) and measures of cognitive functioning, with AR showing the most consistent and robust correlations. As AR increased, overall IQ and specific subtest and area scores from the cognitive tests increased. Conversely, as Amp increased, the overall IQ and specific subtest and area cognitive scores decreased. No significant associations were observed between AR or Amp and measures of behavior or development. The molecular-cognitive associations were generally consistent with the cognitive profile previously described in studies comparing females with fra(X) to age-matched controls. Amp and AR were not associated with one another, nor were they associated with the same cluster of cognitive measures. Though this report does not conclusively show that AR and Amp can be used to clinically assess the risk of a female with the fM for cognitive disability, the evidence presented does suggest that these molecular variables, especially AR, reflect important underlying genetic factors contributing to the fra(X) phenotype.

Original languageEnglish (US)
Pages (from-to)317-327
Number of pages11
JournalAmerican Journal of Medical Genetics
Volume51
Issue number4
DOIs
StatePublished - 1994

Fingerprint

Mutation
X Chromosome
Phenotype

Keywords

  • amplification size
  • behavior
  • fragile X syndrome
  • intelligence
  • methylation

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Molecular-neurobehavioral associations in females with the fragile X full mutation. / Abrams, M. T.; Reiss, A. L.; Freund, L. S.; Baumgardner, T. L.; Chase, G. A.; Denckla, Martha Bridge.

In: American Journal of Medical Genetics, Vol. 51, No. 4, 1994, p. 317-327.

Research output: Contribution to journalArticle

Abrams, M. T. ; Reiss, A. L. ; Freund, L. S. ; Baumgardner, T. L. ; Chase, G. A. ; Denckla, Martha Bridge. / Molecular-neurobehavioral associations in females with the fragile X full mutation. In: American Journal of Medical Genetics. 1994 ; Vol. 51, No. 4. pp. 317-327.
@article{4995ecd9b4be4735b2859821f4c5f60c,
title = "Molecular-neurobehavioral associations in females with the fragile X full mutation",
abstract = "In this study, young females with the fragile X [fra(X)] full mutation (fM) were assessed using quantitative measures of mutation amplification size (Amp) as well as the ratio of active normal X chromosome to total normal X chromosome (activation ratio-AR). Neurobehavioral assessments of females with the fM were performed and included specific and general measures of cognitive and behavioral/developmental functioning. To investigate molecular- behavioral associations, Amp and AR were used as independent variables, while cognitive and behavioral scores were used as dependent variables. Significant correlations were observed between both molecular variables (Amp and AR) and measures of cognitive functioning, with AR showing the most consistent and robust correlations. As AR increased, overall IQ and specific subtest and area scores from the cognitive tests increased. Conversely, as Amp increased, the overall IQ and specific subtest and area cognitive scores decreased. No significant associations were observed between AR or Amp and measures of behavior or development. The molecular-cognitive associations were generally consistent with the cognitive profile previously described in studies comparing females with fra(X) to age-matched controls. Amp and AR were not associated with one another, nor were they associated with the same cluster of cognitive measures. Though this report does not conclusively show that AR and Amp can be used to clinically assess the risk of a female with the fM for cognitive disability, the evidence presented does suggest that these molecular variables, especially AR, reflect important underlying genetic factors contributing to the fra(X) phenotype.",
keywords = "amplification size, behavior, fragile X syndrome, intelligence, methylation",
author = "Abrams, {M. T.} and Reiss, {A. L.} and Freund, {L. S.} and Baumgardner, {T. L.} and Chase, {G. A.} and Denckla, {Martha Bridge}",
year = "1994",
doi = "10.1002/ajmg.1320510407",
language = "English (US)",
volume = "51",
pages = "317--327",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular-neurobehavioral associations in females with the fragile X full mutation

AU - Abrams, M. T.

AU - Reiss, A. L.

AU - Freund, L. S.

AU - Baumgardner, T. L.

AU - Chase, G. A.

AU - Denckla, Martha Bridge

PY - 1994

Y1 - 1994

N2 - In this study, young females with the fragile X [fra(X)] full mutation (fM) were assessed using quantitative measures of mutation amplification size (Amp) as well as the ratio of active normal X chromosome to total normal X chromosome (activation ratio-AR). Neurobehavioral assessments of females with the fM were performed and included specific and general measures of cognitive and behavioral/developmental functioning. To investigate molecular- behavioral associations, Amp and AR were used as independent variables, while cognitive and behavioral scores were used as dependent variables. Significant correlations were observed between both molecular variables (Amp and AR) and measures of cognitive functioning, with AR showing the most consistent and robust correlations. As AR increased, overall IQ and specific subtest and area scores from the cognitive tests increased. Conversely, as Amp increased, the overall IQ and specific subtest and area cognitive scores decreased. No significant associations were observed between AR or Amp and measures of behavior or development. The molecular-cognitive associations were generally consistent with the cognitive profile previously described in studies comparing females with fra(X) to age-matched controls. Amp and AR were not associated with one another, nor were they associated with the same cluster of cognitive measures. Though this report does not conclusively show that AR and Amp can be used to clinically assess the risk of a female with the fM for cognitive disability, the evidence presented does suggest that these molecular variables, especially AR, reflect important underlying genetic factors contributing to the fra(X) phenotype.

AB - In this study, young females with the fragile X [fra(X)] full mutation (fM) were assessed using quantitative measures of mutation amplification size (Amp) as well as the ratio of active normal X chromosome to total normal X chromosome (activation ratio-AR). Neurobehavioral assessments of females with the fM were performed and included specific and general measures of cognitive and behavioral/developmental functioning. To investigate molecular- behavioral associations, Amp and AR were used as independent variables, while cognitive and behavioral scores were used as dependent variables. Significant correlations were observed between both molecular variables (Amp and AR) and measures of cognitive functioning, with AR showing the most consistent and robust correlations. As AR increased, overall IQ and specific subtest and area scores from the cognitive tests increased. Conversely, as Amp increased, the overall IQ and specific subtest and area cognitive scores decreased. No significant associations were observed between AR or Amp and measures of behavior or development. The molecular-cognitive associations were generally consistent with the cognitive profile previously described in studies comparing females with fra(X) to age-matched controls. Amp and AR were not associated with one another, nor were they associated with the same cluster of cognitive measures. Though this report does not conclusively show that AR and Amp can be used to clinically assess the risk of a female with the fM for cognitive disability, the evidence presented does suggest that these molecular variables, especially AR, reflect important underlying genetic factors contributing to the fra(X) phenotype.

KW - amplification size

KW - behavior

KW - fragile X syndrome

KW - intelligence

KW - methylation

UR - http://www.scopus.com/inward/record.url?scp=0028234805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028234805&partnerID=8YFLogxK

U2 - 10.1002/ajmg.1320510407

DO - 10.1002/ajmg.1320510407

M3 - Article

C2 - 7942994

AN - SCOPUS:0028234805

VL - 51

SP - 317

EP - 327

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 4

ER -